TRAITEMENT DU CANCER GASTRIQUE AU MOYEN DE POLYTHERAPIES COMPRENANT DE L'OXALIPLATINE, DU 5-FLUORURACILE (ET DE LA LEUCOVORINE) ET DE L'IRINOTECAN SOUS FORME LIPOSOMALE

• 收藏
• 分享

专利权人:

IPSEN BIOPHARM LTD.

发明人:

ZHANG, BIN,BRAUN, STEPHAN,FITZGERALD, JONATHAN BASIL,KALRA, ASHISH,LEONARD, SHANNON

申请号：

CA3040395

公开号：

CA3040395A1

申请日:

2017.11.01

申请国别(地区):

CA

年份:

2018

代理人:

摘要：

Combination therapy regimens including liposomal irinotecan, oxaliplatin and 5-fluorouracil are useful in the treatment of gastric cancer, including treatment of patients diagnosed with previously untreated gastric cancer. The combination therapy can include the administration of liposomal irinotecan, oxaliplatin, leucovorin and 5-fluorouracil once every two weeks.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/